KNIGHTSBRIDGE ASSET MANAGEMENT, LLC

Position in EXEL — Exelixis, Inc.

CIK 1332811 NEWPORT BEACH, CA

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$295,881

+$59,386 QoQ

Shares Held

5,438

-1.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#519

of 751 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

KNIGHTSBRIDGE ASSET MANAGEMENT, LLC holds $1,397,231 across 4 Biotechnology names. EXEL ranks #3 (21.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	4,677	$530,184
2	REGN	Regeneron Pharmaceuticals, Inc.	594	$370,382
3	EXEL	Exelixis, Inc. This page	5,438	$295,881
4	BMRN	Biomarin Pharmaceutical Inc	3,509	$200,784

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$295,881	5,438	-1.4%	Shares	Sole	2026-08-13
2026-03-31	$236,495	5,514	-18.8%	Shares	Sole	2026-05-15
2025-12-31	$297,561	6,789	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.